Human Amylin: From Pathology to Physiology and Pharmacology

作者: Wei Ling , Yan-Mei Huang , Yong-Chao Qiao , Xiao-Xi Zhang , Hai-Lu Zhao

DOI: 10.2174/1389203720666190328111833

关键词:

摘要: The histopathological hallmark of type 2 diabetes is islet amyloid implicated in the developing treatment options. major component human 37 amino acid peptide known as amylin or polypeptide (IAPP). Amylin an important hormone that co-localized, copackaged, and co-secreted with insulin from β cells. Physiologically, regulates glucose homeostasis by inhibiting glucagon secretion. Furthermore, modulates satiety inhibits gastric emptying via central nervous system. Normally, IAPP soluble natively unfolded its monomeric state. Pathologically, has a propensity to form oligomers aggregate. show misfolded α-helix conformation can further convert themselves β-sheet-rich fibrils deposits. pathological findings physiological functions have led introduction pramlintide, analog, for diabetes. history amylin's discovery representative example how finding translate into exploration lead pharmacological intervention. Understanding importance transitioning pathology physiology pharmacology provide novel insight mellitus Alzheimer's disease.

参考文章(202)
A. Clark, G. J S Cooper, R. R. Holman, J. K. Cruickshank, C. A. Wells, R. I. Vanhegan, I. D. Buley, R. C. Turner, D. R. Matthews, Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes research (Scotland). ,vol. 9, pp. 151- 159 ,(1988)
Roger D. Reidelberger, Urban Arnelo, Lars Granqvist, Johan Permert, Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. American Journal of Physiology-regulatory Integrative and Comparative Physiology. ,vol. 280, ,(2001) , 10.1152/AJPREGU.2001.280.3.R605
Andrew Young, Inhibition of gastric emptying. Advances in pharmacology (San Diego). ,vol. 52, pp. 99- 121 ,(2005) , 10.1016/S1054-3589(05)52006-4
T. J. Williams, S. D. Brain, S. Wimalawansa, I. MacIntyre, The demonstration of vasodilator activity of pancreatic amylin amide in the rabbit. American Journal of Pathology. ,vol. 136, pp. 487- 490 ,(1990)
S. W. B. Ewen, J. M. Polak, A. G. E. Pearse, The genesis of apudamyloid in endocrine polypeptide tumours: histochemical distinction from immunamyloid Virchows Archiv B Cell Pathology. ,vol. 10, pp. 93- 107 ,(1972) , 10.1007/BF02899719
Karl Herrup, The case for rejecting the amyloid cascade hypothesis Nature Neuroscience. ,vol. 18, pp. 794- 799 ,(2015) , 10.1038/NN.4017
Joseph C. Ehrlich, Irving M. Ratner, Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals. American Journal of Pathology. ,vol. 38, pp. 49- 59 ,(1961)
Andrew Young, Central nervous system and other effects. Advances in pharmacology (San Diego). ,vol. 52, pp. 281- 288 ,(2005) , 10.1016/S1054-3589(05)52017-9
Kawser Akter, Emily A. Lanza, Stephen A. Martin, Natalie Myronyuk, Melanie Rua, Robert B. Raffa, Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? British Journal of Clinical Pharmacology. ,vol. 71, pp. 365- 376 ,(2011) , 10.1111/J.1365-2125.2010.03830.X
Andrew Young, Amylin and the Integrated Control of Nutrient Influx Advances in pharmacology (San Diego). ,vol. 52, pp. 67- 77 ,(2005) , 10.1016/S1054-3589(05)52004-0